Page last updated: 2024-11-02

pirenzepine and Hyperphagia

pirenzepine has been researched along with Hyperphagia in 1 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Hyperphagia: Ingestion of a greater than optimal quantity of food.

Research Excerpts

ExcerptRelevanceReference
"The authors explored the binge eating symptomatology in 74 patients receiving clozapine (N = 57) or olanzapine (N = 17), and compared body mass index (BMI, kg/m(2)) and weight gain in patients with and without binge eating symptomatology."7.72Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine. ( Hebebrand, J; König, IR; Linden, A; Martin, M; Remschmidt, H; Theisen, FM, 2003)
"The authors explored the binge eating symptomatology in 74 patients receiving clozapine (N = 57) or olanzapine (N = 17), and compared body mass index (BMI, kg/m(2)) and weight gain in patients with and without binge eating symptomatology."3.72Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine. ( Hebebrand, J; König, IR; Linden, A; Martin, M; Remschmidt, H; Theisen, FM, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Theisen, FM1
Linden, A1
König, IR1
Martin, M1
Remschmidt, H1
Hebebrand, J1

Other Studies

1 other study available for pirenzepine and Hyperphagia

ArticleYear
Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine.
    Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:1

    Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Bulimia; Clozapine; Femal

2003